Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Marta, Jeison"'
Autor:
Angela, Bellini, Ulrike, Pötschger, Virginie, Bernard, Eve, Lapouble, Sylvain, Baulande, Peter F, Ambros, Nathalie, Auger, Klaus, Beiske, Marie, Bernkopf, David R, Betts, Jaydutt, Bhalshankar, Nick, Bown, Katleen, de Preter, Nathalie, Clément, Valérie, Combaret, Jaime, Font de Mora, Sally L, George, Irene, Jiménez, Marta, Jeison, Barbara, Marques, Tommy, Martinsson, Katia, Mazzocco, Martina, Morini, Annick, Mühlethaler-Mottet, Rosa, Noguera, Gaelle, Pierron, Maria, Rossing, Sabine, Taschner-Mandl, Nadine, Van Roy, Ales, Vicha, Louis, Chesler, Walentyna, Balwierz, Victoria, Castel, Martin, Elliott, Per, Kogner, Geneviève, Laureys, Roberto, Luksch, Josef, Malis, Maja, Popovic-Beck, Shifra, Ash, Olivier, Delattre, Dominique, Valteau-Couanet, Deborah A, Tweddle, Ruth, Ladenstein, Gudrun, Schleiermacher
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(30)
In neuroblastoma (NB), the ALK receptor tyrosine kinase can be constitutively activated through activating point mutations or genomic amplification. We studiedDiagnostic tumor samples were available from 1,092 HR-NBL1/SIOPEN patients to determineGeno
Autor:
Ulrike Pötschger, Gudrun Schleiermacher, Sally L George, Nick Bown, Jaydutt Bhalshankar, Sylvain Baulande, Peter F. Ambros, Josef Malis, Gaëlle Pierron, Eve Lapouble, Katia Mazzocco, Virginie Bernard, Jaime Font de Mora, Katleen De Preter, Annick Mühlethaler-Mottet, Nadine Van Roy, Martina Morini, Genevieve Laureys, Bárbara Marques, Dominique Valteau-Couanet, Olivier Delattre, Marta Jeison, Victoria Castel, Shifra Ash, Valérie Combaret, Nathalie Auger, Ruth Ladenstein, Sabine Taschner-Mandl, Louis Chesler, Maria Rossing, David R. Betts, Ales Vicha, Rosa Noguera, Klaus Beiske, Angela Bellini, Walentyna Balwierz, Deborah A. Tweddle, Maja Popovic-Beck, Marie Bernkopf, Nathalie Clément, Per Kogner, Tommy Martinsson, Roberto Luksch, Martin Elliott, Irene Jiménez
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
Bellini, A, Potschger, U, Bernard, V, Lapouble, E, Baulande, S, Ambros, P F, Auger, N, Beiske, K, Bernkopf, M, Betts, D R, Bhalshankar, J, Bown, N, De Preter, K, Clement, N, Combaret, V, De Mora, J F, George, S L, Jimenez, I, Jeison, M, Marques, B, Martinsson, T, Mazzocco, K, Morini, M, Muhlethaler-Mottet, A, Noguera, R, Pierron, G, Rossing, M, Taschner-Mandl, S, Van Roy, N, Vicha, A, Chesler, L, Balwierz, W, Castel, V, Elliott, M, Kogner, P, Laureys, G, Luksch, R, Malis, J, Popovic-Beck, M, Ash, S, Delattre, O, Valteau-Couanet, D, Tweddle, D A, Ladenstein, R & Schleiermacher, G 2021, ' Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1) ', Journal of Clinical Oncology, vol. 39, no. 30, pp. 3377-3390 . https://doi.org/10.1200/JCO.21.00086
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Journal of clinical oncology, vol. 39, no. 30, pp. 3377-3390
Bellini, A, Potschger, U, Bernard, V, Lapouble, E, Baulande, S, Ambros, P F, Auger, N, Beiske, K, Bernkopf, M, Betts, D R, Bhalshankar, J, Bown, N, De Preter, K, Clement, N, Combaret, V, De Mora, J F, George, S L, Jimenez, I, Jeison, M, Marques, B, Martinsson, T, Mazzocco, K, Morini, M, Muhlethaler-Mottet, A, Noguera, R, Pierron, G, Rossing, M, Taschner-Mandl, S, Van Roy, N, Vicha, A, Chesler, L, Balwierz, W, Castel, V, Elliott, M, Kogner, P, Laureys, G, Luksch, R, Malis, J, Popovic-Beck, M, Ash, S, Delattre, O, Valteau-Couanet, D, Tweddle, D A, Ladenstein, R & Schleiermacher, G 2021, ' Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1) ', Journal of Clinical Oncology, vol. 39, no. 30, pp. 3377-3390 . https://doi.org/10.1200/JCO.21.00086
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Journal of clinical oncology, vol. 39, no. 30, pp. 3377-3390
Purpose: In neuroblastoma (NB), the ALK receptor tyrosine kinase can be constitutively activated through activating point mutations or genomic amplification. We studied ALK genetic alterations in high-risk (HR) patients on the HR-NBL1/SIOPEN trial to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f945798aee88bde13807004951fe9f5
https://hdl.handle.net/1854/LU-8743680
https://hdl.handle.net/1854/LU-8743680
Autor:
Galina Feinberg-Gorenshtein, Avital Guedj, Keren Shichrur, Marta Jeison, Drorit Luria, Yona Kodman, Shifra Ash, Meora Feinmesser, Liat Edry, Noam Shomron, Abraham Weizman, Isaac Yaniv, Smadar Avigad
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78713 (2013)
Neuroblastoma (NB) arises from the embryonic neural crest and is the most common extracranial solid tumor in children under 5 years of age. Reduced expression of Dicer1 has recently been shown to be in correlation with poor prognosis in NB patients.
Externí odkaz:
https://doaj.org/article/7d07ceea9abd4218a5d183baddbabbcc
Autor:
Orly Dgany, Asaf D Yanir, Tanya Krasnov, Shai Izraeli, Helen Toledano, Oded Gilad, Sharon Noy-Lotan, Hannah Tamary, Joanne Yacobovich, Marta Jeison, Orna Steinberg-Shemer, Shlomit Barzilai-Birenboim
Publikováno v:
British journal of haematologyReferences. 193(3)
Detection of somatic mutations may help verify the diagnosis of myelodysplastic syndrome (MDS) in patients with persistent cytopenias or with MDS-predisposition syndromes, prior to the development of overt leukemia. However, the spectrum and conseque
Autor:
Paula Kjollerstrom, Marta Derecka, Brigitte Schlegelberger, Peter Lang, Dirk Lebrecht, Manching Ku, Birgit Burkhardt, Robert Durruthy-Durruthy, Marcin W. Wlodarski, Martin Čermák, Albert Català, Kalliopi Manola, Nadine Van Roy, Ingrid Simonitsch-Kluppp, Roos Leguit, Peter Bader, Barbara Gazic, Yaniv Zohar, Kalliopi Stefanaki, Michael Dworzak, Maureen O’Sullivan, Roland Meisel, Sophia Polychronopoulou, Emilia J Kozyra, Rita De Vito, David Betts, Pritam Kumar Panda, Amina Szvetnik, Peter Noellke, Brigitte Strahm, Julius Wehrle, Helena Podgornik, Carole Gengler, Valerie de Haas, Krisztián Kállay, Zuzana Zemanova, Luis Mascarenhas de Lemos, Marena R. Niewisch, Joelle Tchinda, Ayami Yoshimi-Noellke, Margarita Llavador Ros, Charlotte M. Niemeyer, Ivana Bodova, Gunnar Cario, Charnise Goodings, Berna Beverloo, Karin Nebral, Hajnalka Andrikovics, Dominik Turkiewicz, Pascale De Paepe, Sushree S. Sahoo, Owen P. Smith, Christian Flotho, Jan Starý, Marek Ussowicz, Jadwiga Maldyk, Riccardo Masetti, Stephan Schwarz-Furlan, Gudrun Göhring, Vit Campr, Francesco Pasquali, Irith Baumann, Henrik Hasle, Michael H. Albert, Shlomit Barzilai, Oksana Fabri, Helena Alaiz, Erik Clasen-Linde, Victor B Pastor, Miriam Erlacher, Kirsi Jahnukainen, Tine Plesner, Franco Locatelli, Olga Haus, Rebecca K Voss, Marta Jeison, Lukas Plank, Markus Schmugge, Rita Beier, José Cervera, Barbara De Moerloose, Owen Smith, Martina Rudelius, Ingo Müller, Jochen Buechner, Marko Kavcic, Martin Sauer, Ansgar Schulz, Judit Csomor, Shinsuke Hirabayashi
Publikováno v:
Nature Medicine. 27:2248-2248
Autor:
Marcin Braun, Grigory Tsaur, Larisa Fechina, Rob Pieters, Ingegerd Ivanov Öfverholm, Lina Hamadeh, Karin Nebral, Gisela Barbany, Jan Stary, Maria S. Felice, Mariana Emerenciano, Mio Yano, Marta Jeison, Sarah Elitzur, Monique L. den Boer, Henriett Pikó, Luciano Dalla Pozza, Gabor G. Kovacs, Maria S. Pombo-de-Oliveira, Wojciech Młynarski, Roland P. Kuiper, Keizo Horibe, Rosemary Sutton, Sabine Strehl, Amir Enshaei, Nicola C. Venn, Agata Pastorczak, Eva Fronkova, Judith M. Boer, Patricia L. Rubio, Anthony V. Moorman, Irén Haltrich, Andishe Attarbaschi, Cristina N. Alonso, Ajay Vora, Mats Heyman, Jan Trka, Claire Schwab, Christine J. Harrison, Toshihiko Imamura
Publikováno v:
Blood Advances, 3, 2, pp. 148-157
Blood Advances, 3, 148-157
Blood Advances, 3, 148-157
Contains fulltext : 204641.pdf (Publisher’s version ) (Open Access) Genetic abnormalities provide vital diagnostic and prognostic information in pediatric acute lymphoblastic leukemia (ALL) and are increasingly used to assign patients to risk group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf3dd283d1b3cc4b5b525fddbefd790
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/204641
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/204641
Autor:
Asaf Lebel, Smadar Avigad, Oshrit Kordi, Isaac Yaniv, Jan Trka, Drorit Luria, Sarah Elitzur, Hadar Mirsky, Anat Ohali, Keren Shichrur, Yona Kodman, Dafna Gaash, Eva Fronkova, Gertjan J.L. Kaspers, Iedan Rn Verly, Galia Avrahami, Gil Gilad, Batia Stark, Marta Jeison, Michal Hameiri-Grossman, Jacqueline Cloos
Publikováno v:
Genes, Chromosomes and Cancer. 55:328-339
Our aim was to identify miRNAs that can predict risk of relapse in pediatric patients with acute lymphoblastic leukemia (ALL). Following high-throughput miRNA expression analysis (48 samples), five miRs were selected for further confirmation performe
Autor:
Shifra Ash, Gudrun Schleiermacher, Frank Berthold, Genevieve Laureys, Joëlle Vermeulen, Valérie Combaret, Tim Lammens, Katrien Vanderheyden, Ana P. Berbegall, Frank Speleman, Hetty Helsmoortel, Jo Vandesompele, Alexander Schramm, Julie Bienertova Vasku, Katleen De Preter, Rosa Noguera, Matthias Fischer, Johannes H. Schulte, Anneleen Decock, Pieter Mestdagh, Sven Rahmann, Marta Jeison, Fjoralba Zeka, Jason M. Shohet, Alan Van Goethem, Mirthala Moreno-Smith, Michael D. Hogarty, Eveline Barbieri, Fleur Demuynck, Pavel Mazánek
In this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of non-invasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743 miRNAs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78bbb4524beed582c494c622c63a744f
Autor:
Frank Berthold, Frank Speleman, Ana P. Berbegall, Katrien Vanderheyden, Julie Bienertova Vasku, Matthias Fischer, Shifra Ash, Jo Vandesompele, Michael D. Hogarty, Fleur Demuynck, Fjoralba Zeka, Sven Rahmann, Johannes H. Schulte, Joëlle Vermeulen, Marta Jeison, Rosa Noguera, Gudrun Schleiermacher, Jason M. Shohet, Pieter Mestdagh, Genevieve Laureys, Alan Van Goethem, Tom Van Maerken, Eveline Barbieri, Mirthala Moreno-Smith, Anneleen Decock, Katleen De Preter, Hetty Helsmoortel, Alexander Schramm, Valérie Combaret, Pavel Mazánek, Tim Lammens
Publikováno v:
Jci Insight
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
In this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of noninvasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743 miRNAs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ed23013cb440a2022a624ff882c1ed
https://www.ncbi.nlm.nih.gov/pubmed/30518699
https://www.ncbi.nlm.nih.gov/pubmed/30518699
Autor:
Rosa Noguera, Peter F. Ambros, Carole Coze, Dominik Bogen, Katia Mazzocco, Raffaella Defferrari, Klaus Beiske, Vassilios Papadakis, Gabriele Amann, Ellen Ruud, Angela Rita Sementa, Inge M. Ambros, Luigi Varesio, Valérie Combaret, Samuel Navarro, Victoria Castel, Ana P. Berbegall, Marta Jeison, Ruth Ladenstein, Nick Bown, Cormac Owens, Ulrike Pötschger, Ales Vicha, Shifra Ash
Publikováno v:
BRITISH JOURNAL OF CANCER
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
British Journal of Cancer
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
British Journal of Cancer
Background In neuroblastoma (NB), the most powerful prognostic marker, the MYCN amplification (MNA), occasionally shows intratumoural heterogeneity (ITH), i.e. coexistence of MYCN-amplified and non-MYCN-amplified tumour cell clones, called heterogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885658426a76bef79c7bae3ea38795a9
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2502
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2502